Oak Thistle’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Sell
709
-3,652
-84% -$2M 0.03% 433
2026
Q2
$2.3M Buy
+4,361
New +$2.45M 0.22% 178
2026
Q1
– Sell
-1,168
Closed -$790K – 549
2025
Q4
$790K Buy
+1,168
New +$795K 0.11% 365
2025
Q3
– Sell
-2,843
Closed -$1.52M – 546
2025
Q2
$1.52M Buy
+2,843
New +$1.36M 0.22% 164
2025
Q1
– Sell
-1,031
Closed -$426K – 489
2024
Q4
$426K Buy
+1,031
New +$452K 0.13% 276
2024
Q3
– Sell
-869
Closed -$423K – 464
2024
Q2
$423K Buy
869
+319
+58% +$160K 0.31% 138
2024
Q1
$297K Buy
+550
New +$301K 0.27% 174
2023
Q4
– Sell
-830
Closed -$363K – 528
2023
Q3
$363K Buy
830
+265
+47% +$132K 0.11% 357
2023
Q2
$284K Sell
565
-372
-40% -$178K 0.15% 263
2023
Q1
$469K Buy
+937
New +$448K 0.28% 152
2022
Q2
– Sell
-724
Closed -$396K – 287
2022
Q1
$396K Buy
+724
New +$381K 0.21% 216

Other funds holding IDXX

Oak Thistle's IDXX Position: Q3 2026 in Review

Oak Thistle reduced its Idexx Laboratories (IDXX) stake by 84% in Q3 2026, selling an estimated $2M and leaving 709 shares worth $370K. The position accounts for 0.03% of the portfolio, ranked #433.

Oak Thistle first reported a position in IDXX in Q1 2022 and has held it in 11 quarters since. The position peaked at $2.3M in Q2 2026. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Oak Thistle held 709 shares of Idexx Laboratories worth $370K as of Q3 2026.
  • Oak Thistle sold 3,652 Idexx Laboratories shares in Q3 2026, an estimated $2M.
  • Idexx Laboratories made up 0.03% of Oak Thistle's portfolio in Q3 2026, its #433 holding.
  • Oak Thistle first reported a position in Idexx Laboratories in Q1 2022 and has held it in 11 quarters since.
  • Oak Thistle's Idexx Laboratories position peaked at $2.3M in Q2 2026.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.